Abstract

ABSTRACTAll enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Viral fusion is mediated by a viral surface protein that transits from an initial prefusion conformation to a final postfusion conformation. Strikingly, the prefusion conformation of the herpesvirus fusion protein, gB, is poorly understood. Herpes simplex virus (HSV), a model system for herpesviruses, causes diseases ranging from mild skin lesions to serious encephalitis and neonatal infections. Using cryo-electron tomography and subtomogram averaging, we have characterized the structure of the prefusion conformation and fusion intermediates of HSV-1 gB. To this end, we have set up a system that generates microvesicles displaying full-length gB on their envelope. We confirmed proper folding of gB by nondenaturing electrophoresis-Western blotting with a panel of monoclonal antibodies (MAbs) covering all gB domains. To elucidate the arrangement of gB domains, we labeled them by using (i) mutagenesis to insert fluorescent proteins at specific positions, (ii) coexpression of gB with Fabs for a neutralizing MAb with known binding sites, and (iii) incubation of gB with an antibody directed against the fusion loops. Our results show that gB starts in a compact prefusion conformation with the fusion loops pointing toward the viral membrane and suggest, for the first time, a model for gB’s conformational rearrangements during fusion. These experiments further illustrate how neutralizing antibodies can interfere with the essential gB structural transitions that mediate viral entry and therefore infectivity.

Highlights

  • All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs

  • It is estimated that over 3.5 billion people worldwide are infected with Herpes simplex virus (HSV)-1, while over 400 million people are infected with HSV-2, an infection that has been shown to increase the risk of HIV acquisition [1]

  • Rogalin and Heldwein have recently generated vesicular stomatitis virus (VSV) particles pseudotyped with HSV-1 gD, gH/gL, and gB, and these particles were found to be able to infect cells expressing gD’s receptor, showing that gD, gH/gL, and gB are essential and presumably sufficient for HSV cell entry [22]

Read more

Summary

Introduction

All enveloped viruses, including herpesviruses, must fuse their envelope with the host membrane to deliver their genomes into target cells, making this essential step subject to interference by antibodies and drugs. Our results show that gB starts in a compact prefusion conformation with the fusion loops pointing toward the viral membrane and suggest, for the first time, a model for gB’s conformational rearrangements during fusion These experiments further illustrate how neutralizing antibodies can interfere with the essential gB structural transitions that mediate viral entry and infectivity. Herpesviruses must fuse their envelope with the host membrane to start an infection This process is mediated by a viral surface protein that transitions from an initial conformation (prefusion) to a final, more stable, conformation (postfusion). Herpes simplex virus (HSV) is a model system for the herpesvirus family, which includes human viruses that cause lifelong infections and a variety of diseases, including skin lesions, encephalitis, and cancers. Rogalin and Heldwein have recently generated vesicular stomatitis virus (VSV) particles pseudotyped with HSV-1 gD, gH/gL, and gB, and these particles were found to be able to infect cells expressing gD’s receptor, showing that gD, gH/gL, and gB are essential and presumably sufficient for HSV cell entry [22]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call